Skip to main content

Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966

Objective

The PREFER project will deliver an overview and evaluation of preference elicitation methods to be applied in the entire drug life cycle, i.e. in the early stages of identifying medical needs, in clinical testing, to guide decisions on reimbursement and to make decisions on withdrawal of drugs from the market. A broad array of (combinations of) patient preference methods will be tested prospectively in a large number of case studies. The availability of large patient cohorts will enable to test new methods or deviations from existing methods in a randomized manner, by comparing well-known methods with newer ones. The use of simulation studies will both contribute to smarter design of case studies and to exploring the sensitivity of outcomes of preference studies. Based on discussions with a broad representation of stakeholders e.g. patients, patient organisations, regulatory authorities, HTA bodies and reimbursement agencies, suitable methods will be tested and their contributions to improved decision making will be discussed in recommendations adapted to the needs of all relevant stakeholders. The recommendations from PREFER are expected to lead to changed practices, in that industry will routinely assess whether a preference study would add value at key decision points in the medicinal product life cycle and, if so, implement patient-preference elicitation studies according to the PREFER project recommendations. The PREFER consortium consist of 16 industry partners and 16 academic and SME members including representation from academia, patient organizations, HTA bodies, reimbursement agencies, and project management.

Call for proposal

H2020-JTI-IMI2-2015-05-two-stage
See other projects for this call

Funding Scheme

IMI2-RIA - Research and Innovation action

Coordinator

UPPSALA UNIVERSITET
Address
Von Kraemers Alle 4
751 05 Uppsala
Sweden
Activity type
Higher or Secondary Education Establishments
EU contribution
€ 1 566 849

Participants (32)

UNIVERSITAIR MEDISCH CENTRUM UTRECHT
Netherlands
EU contribution
€ 618 672
Address
Heidelberglaan 100
3584 CX Utrecht
Activity type
Higher or Secondary Education Establishments
ERASMUS UNIVERSITEIT ROTTERDAM
Netherlands
EU contribution
€ 551 125
Address
Burgemeester Oudlaan 50
3062 PA Rotterdam
Activity type
Higher or Secondary Education Establishments
KATHOLIEKE UNIVERSITEIT LEUVEN
Belgium
EU contribution
€ 683 750
Address
Oude Markt 13
3000 Leuven
Activity type
Higher or Secondary Education Establishments
THE UNIVERSITY OF BIRMINGHAM
United Kingdom
EU contribution
€ 238 750
Address
Edgbaston
B15 2TT Birmingham
Activity type
Higher or Secondary Education Establishments
UNIVERSITATSKLINIKUM ERLANGEN
Germany
EU contribution
€ 233 722
Address
Maximiliansplatz 2
91054 Erlangen
Activity type
Higher or Secondary Education Establishments
ISTITUTO EUROPEO DI ONCOLOGIA SRL
Italy
EU contribution
€ 335 000
Address
Via Filodrammatici 10
20121 Milano
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
MINDBYTES
Belgium
EU contribution
€ 259 937
Address
Schoondreef 7
2330 Merksplas
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
"INSTITUTO TUMORI ""GIOVANNI PAOLO II"""
Italy
EU contribution
€ 233 275
Address
Via Orazio Flacco 65
70126 Bari
Activity type
Research Organisations
EUROPEAN CANCER PATIENT COALITION
Belgium
EU contribution
€ 223 250
Address
Rue Montoyer 40
1000 Bruxelles
Activity type
Other
STEINBEISSER PROJECT MANAGEMENT UG (HAFTUNGSBESCHRANKT)
Germany
EU contribution
€ 262 500
Address
Prinzregentenstrasse 100
81677 Munchen
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
UNIVERSITY OF NEWCASTLE UPON TYNE
United Kingdom
EU contribution
€ 264 922
Address
Kings Gate
NE1 7RU Newcastle Upon Tyne
Activity type
Higher or Secondary Education Establishments
CENTRE FEDERAL D'EXPERTISE DES SOINS DE SANTE
Belgium
EU contribution
€ 252 500
Address
Boulevard Du Jardin Botanique 55
1000 Bruxelles
Activity type
Research Organisations
MUSCULAR DYSTROPHY GROUP OF GREAT BRITAIN AND NORTHERN IRELAND
United Kingdom
EU contribution
€ 80 000
Address
61A Great Suffolk Street
SE1 0BU London
Activity type
Other
NOVARTIS PHARMA AG
Switzerland
EU contribution
€ 0
Address
Lichtstrasse 35
4056 Basel
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
AMGEN LIMITED
United Kingdom
EU contribution
€ 0
Address
Cambridge Science Park - Milton Road 240
CB4 0WD Cambridge
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
ASTELLAS PHARMA EUROPE BV
Netherlands
EU contribution
€ 0
Address
Sylviusweg 84
2333 BE Leiden
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Bayer Pharma AG
Germany
EU contribution
€ 0
Address
Muellerstrasse 178
13353 Berlin
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Eli Lilly and Company Limited
United Kingdom
EU contribution
€ 0
Address
Lilly House, Priestley Road
RG24 9NL Basingstoke
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
JANSSEN PHARMACEUTICA NV
Belgium
EU contribution
€ 0
Address
Turnhoutseweg 30
2340 Beerse
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT
France
EU contribution
€ 0
Address
Pierre Brossolette 1
91380 Chilly Mazarin
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
ACTELION PHARMACEUTICALS LTD
Switzerland
EU contribution
€ 0
Address
Gewerbestrasse 16
4123 Allschwil
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
PFIZER LIMITED
United Kingdom
EU contribution
€ 0
Address
Ramsgate Road
CT13 9NJ Sandwich
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
MERCK SHARP & DOHME CORP
United States
EU contribution
€ 0
Address
One Merck Drive
08889 Whitehouse Station Nj
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
ASTRAZENECA AB
Sweden
EU contribution
€ 0
Address
Vastra Maelarhamnen
151 85 Sodertaelje
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
CSL BEHRING GMBH
Germany
EU contribution
€ 0
Address
Emil Von Behring Strasse 76
35041 Marburg
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN
Germany
EU contribution
€ 0
Address
Frankfurter Strasse 250
64293 Darmstadt
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
F. HOFFMANN-LA ROCHE AG
Switzerland
EU contribution
€ 0
Address
Grenzacherstrasse 124
4070 Basel
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
AbbVie Ltd
United Kingdom
EU contribution
€ 0
Address
Vanwall Road
SL6 4XE Maidenhead
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
TAKEDA DEVELOPMENT CENTRE EUROPE LTD
United Kingdom
EU contribution
€ 0
Address
Aldwych 61
WC2B 4AE London
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
FORUM EUROPEEN DES PATIENTS (FPE)
Luxembourg
EU contribution
€ 65 000
Address
Rue Dicks 14
1417 Luxembourg
Activity type
Other
INTERNATIONAL ALLIANCE OF PATIENT'ORGANIZATIONS
United Kingdom
EU contribution
€ 63 173
Address
49-51 East Road
N1 6AH London
Activity type
Other
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM
Netherlands
EU contribution
€ 67 575
Address
Dr Molewaterplein 40
3015 GD Rotterdam
Activity type
Higher or Secondary Education Establishments